Cohance Lifesciences board appoints Dr. Kuber Jagdale as Additional Director/ CTO & ED

The board of Cohance Lifesciences at its meeting held on 06 November 2026 has approved the appointment of Dr. Kuber Jagdale (DIN: 12037580) as an Additional Director, designated as Chief Technical Officer & Executive Director for a period of 5 (five) years effective from 7 November 2026 till 6 November 2031.